Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance
Science Advances · 2023-12 · 9 (48)
DOI: 10.1126/sciadv.adh1891 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023-12. Verfasst von Jihong Cui und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Breast Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Cancer stem cells (CSCs) drive tumor growth, metastasis, and chemoresistance. While emerging evidence suggests that CSCs have a unique dependency on lipid metabolism, the functions and regulation of distinct lipid species in CSCs remain poorly understood. Here, we developed a stem cell factor SOX9-based reporter for isolating CSCs in primary tumors and metastases of spontaneous mammary tumor models. Transcriptomic analyses uncover that SOX9 high CSCs up-regulate the ABCA12 lipid transporter. ABCA12 down-regulation impairs cancer stemness and chemoresistance. Lipidomic analyses reveal that ABCA12 maintains cancer stemness and chemoresistance by reducing intracellular ceramide abundance, identifying a CSC-associated function of ABCA subfamily transporter. Ceramide suppresses cancer stemness by inhibiting the YAP-SOX9 signaling pathway in CSCs. Increasing ceramide levels in tumors enhances their sensitivity to chemotherapy and prevents the enrichment of SOX9 high CSCs. In addition, SOX9 high and ABCA12 high cancer cells contribute to chemoresistance in human patient-derived xenografts. These findings identify a CSC-suppressing lipid metabolism pathway that can be exploited to inhibit CSCs and overcome chemoresistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
- Montefiore Einstein Cancer Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
ORCID-Profile: Jihong Cui, John R Christin, Julie A Reisz, Francesca Isabelle Cendali, Rahul Sanawar, Marcelo Coutinho De Miranda, Angelo D'Alessandro, Wenjun Guo
Förderung
- NCI NIH HHS
- NIH HHS
Zitieren
APA
Cui, J., Christin, J. R., Reisz, J. A., Cendali, F. I., Sanawar, R., Coutinho De Miranda, M., D'Alessandro, A., & Guo, W. (2023). Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance. Science Advances, 9(48). https://doi.org/10.1126/sciadv.adh1891
Vancouver
Cui J, Christin JR, Reisz JA, Cendali FI, Sanawar R, Coutinho De Miranda M, et al. Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance. Science Advances. 2023;9(48). doi:10.1126/sciadv.adh1891
BibTeX
@article{Cui2023,
author = {Cui, Jihong and Christin, John R and Reisz, Julie A and Cendali, Francesca Isabelle and Sanawar, Rahul and Coutinho De Miranda, Marcelo and D'Alessandro, Angelo and Guo, Wenjun},
title = {Targeting ABCA12-controlled ceramide homeostasis inhibits breast cancer stem cell function and chemoresistance},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {48},
doi = {10.1126/sciadv.adh1891}
}
EUVIMED